{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-24-005496","form_type":"8-K","ticker":"SBFM","cik":"0001402328","company_name":"Sunshine Biopharma Inc.","filed_at":"2024-08-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.921701+00:00","generated_at":"2026-05-31T09:59:38.902543+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Sunshine Biopharma announces 1-for-20 reverse stock split, effective Aug 8","bullets":["1-for-20 reverse stock split effective August 8, 2024; each share converted to one-twentieth of a share.","Certificate of amendment filed with Colorado Secretary of State on August 7, 2024.","Reverse split applies to all outstanding shares of common stock; no change in authorized shares or par value."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-24-005496","json":"https://secwatch.observer/filing/0001683168-24-005496.json","markdown":"https://secwatch.observer/filing/0001683168-24-005496.md","text":"https://secwatch.observer/filing/0001683168-24-005496.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1402328/000168316824005496/0001683168-24-005496-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1402328/000168316824005496/sunshine_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T09:59:38.902543+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}